Dushyanth Jyothi
Research Subjects
Dushyanth Jyothi has a total of 504 co-authors. Here are the top co-authors by number of shared publications:
- Dominic P. Kwiatkowski
Wellcome Sanger Institute
8 shared publications Eleanor Drury
Hinxton Wellcome Sanger Institute
7 shared publications- Lucas Amenga-Etego
West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana
6 shared publications Chanaki Amaratunga
National Institute of Allergy and Infectious Diseases (NIAID) Bethesda NIH
5 shared publicationsJacob Almagro-Garcia
MRC Centre for Genomics and Global Health Oxford Big Data Institute, University of Oxford
5 shared publications- Magnus Manske
Wellcome Trust Sanger Institute, Cambridge, United Kingdom
5 shared publications
Latest Publications
- Open Access
A novel method to select Reference Proteomes in UniProt
Motivation: The ongoing revolution in genome sequencing is delivering an unprecedented number of genome assemblies to global repositories, resulting in an overwhelming amount of data imported to UniProt in the form of proteomes. To manage this growth sustainably, there is a need for a systematic workflow to select the best proteomes. Results: We propose a novel pipeline for cellular organisms to select the best Reference Proteomes, i.e. those that best represent the protein space of a species. The pipeline uses a clustering algorithm based on MMseqs2 to select the minimum number of Reference Proteomes whilst maximising the representation of the protein space for each species. Additionally, we aligned our viral Reference Proteomes with the exemplar genome set defined by the International Committee on Taxonomy of Viruses. Because this method ensures that all species are represented with at least one Reference Proteome, the UniProt Knowledgebase increased the number of Reference Proteomes of 36% and covering 34% more species in the Tree of Life. The UniProt Knowledgebase will mainly retain proteins from Reference Proteomes and therefore this method reduces the overall number of proteins by 43%, leading to a more concise yet representative knowledgebase. Availability and Implementation: https://www.uniprot.org/proteomes Contact: raposo@ebi.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.
Open AccessA novel method to select Reference Proteomes in UniProt
Motivation: The ongoing revolution in genome sequencing is delivering an unprecedented number of genome assemblies to global repositories, resulting in an overwhelming amount of data imported to UniProt in the form of proteomes. To manage this growth sustainably, there is a need for a systematic workflow to select the best proteomes. Results: We propose a novel pipeline for cellular organisms to select the best Reference Proteomes, i.e. those that best represent the protein space of a species. The pipeline uses a clustering algorithm based on MMseqs2 to select the minimum number of Reference Proteomes whilst maximising the representation of the protein space for each species. Additionally, we aligned our viral Reference Proteomes with the exemplar genome set defined by the International Committee on Taxonomy of Viruses. Because this method ensures that all species are represented with at least one Reference Proteome, the UniProt Knowledgebase increased the number of Reference Proteomes of 36% and covering 34% more species in the Tree of Life. The UniProt Knowledgebase will mainly retain proteins from Reference Proteomes and therefore this method reduces the overall number of proteins by 43%, leading to a more concise yet representative knowledgebase. Availability and Implementation: https://www.uniprot.org/proteomes Contact: raposo@ebi.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.
- Open Access
- 13 July 2021
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 6, 42
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
MalariaGEN is a data-sharing network that enables groups around the world to work together on the genomic epidemiology of malaria. Here we describe a new release of curated genome variation data on 7,000 Plasmodium falciparum samples from MalariaGEN partner studies in 28 malaria-endemic countries. High-quality genotype calls on 3 million single nucleotide polymorphisms (SNPs) and short indels were produced using a standardised analysis pipeline. Copy number variants associated with drug resistance and structural variants that cause failure of rapid diagnostic tests were also analysed. Almost all samples showed genetic evidence of resistance to at least one antimalarial drug, and some samples from Southeast Asia carried markers of resistance to six commonly-used drugs. Genes expressed during the mosquito stage of the parasite life-cycle are prominent among loci that show strong geographic differentiation. By continuing to enlarge this open data resource we aim to facilitate research into the evolutionary processes affecting malaria control and to accelerate development of the surveillance toolkit required for malaria elimination.
- 13 July 2021
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 6, 42
Open AccessAn open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
MalariaGEN is a data-sharing network that enables groups around the world to work together on the genomic epidemiology of malaria. Here we describe a new release of curated genome variation data on 7,000 Plasmodium falciparum samples from MalariaGEN partner studies in 28 malaria-endemic countries. High-quality genotype calls on 3 million single nucleotide polymorphisms (SNPs) and short indels were produced using a standardised analysis pipeline. Copy number variants associated with drug resistance and structural variants that cause failure of rapid diagnostic tests were also analysed. Almost all samples showed genetic evidence of resistance to at least one antimalarial drug, and some samples from Southeast Asia carried markers of resistance to six commonly-used drugs. Genes expressed during the mosquito stage of the parasite life-cycle are prominent among loci that show strong geographic differentiation. By continuing to enlarge this open data resource we aim to facilitate research into the evolutionary processes affecting malaria control and to accelerate development of the surveillance toolkit required for malaria elimination.
- Top Cited PapersOpen Access
- 24 February 2021
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 6, 42
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
MalariaGEN is a data-sharing network that enables groups around the world to work together on the genomic epidemiology of malaria. Here we describe a new release of curated genome variation data on 7,000 Plasmodium falciparum samples from MalariaGEN partner studies in 28 malaria-endemic countries. High-quality genotype calls on 3 million single nucleotide polymorphisms (SNPs) and short indels were produced using a standardised analysis pipeline. Copy number variants associated with drug resistance and structural variants that cause failure of rapid diagnostic tests were also analysed. Almost all samples showed genetic evidence of resistance to at least one antimalarial drug, and some samples from Southeast Asia carried markers of resistance to six commonly-used drugs. Genes expressed during the mosquito stage of the parasite life-cycle are prominent among loci that show strong geographic differentiation. By continuing to enlarge this open data resource we aim to facilitate research into the evolutionary processes affecting malaria control and to accelerate development of the surveillance toolkit required for malaria elimination.
- 24 February 2021
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 6, 42
Top Cited PapersOpen AccessAn open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
MalariaGEN is a data-sharing network that enables groups around the world to work together on the genomic epidemiology of malaria. Here we describe a new release of curated genome variation data on 7,000 Plasmodium falciparum samples from MalariaGEN partner studies in 28 malaria-endemic countries. High-quality genotype calls on 3 million single nucleotide polymorphisms (SNPs) and short indels were produced using a standardised analysis pipeline. Copy number variants associated with drug resistance and structural variants that cause failure of rapid diagnostic tests were also analysed. Almost all samples showed genetic evidence of resistance to at least one antimalarial drug, and some samples from Southeast Asia carried markers of resistance to six commonly-used drugs. Genes expressed during the mosquito stage of the parasite life-cycle are prominent among loci that show strong geographic differentiation. By continuing to enlarge this open data resource we aim to facilitate research into the evolutionary processes affecting malaria control and to accelerate development of the surveillance toolkit required for malaria elimination.
- Open Access
- 1 August 2018
- Published by Elsevier in The Lancet Haematology
- Vol. 5 (8) , e333-e345
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study
- 1 August 2018
- Published by Elsevier in The Lancet Haematology
- Vol. 5 (8) , e333-e345
Open AccessHuman candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study
- Top Cited PapersOpen Access
- 1 February 2017
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 17 (2) , 164-173
Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study
- 1 February 2017
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 17 (2) , 164-173
Top Cited PapersOpen AccessGenetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study
- Top Cited PapersOpen Access
- 20 December 2016
- Published by Springer Nature in Malaria Journal
- Vol. 15 (1) , 1-12
Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification
Translating genomic technologies into healthcare applications for the malaria parasite Plasmodium falciparum has been limited by the technical and logistical difficulties of obtaining high quality clinical samples from the field. Sampling by dried blood spot (DBS) finger-pricks can be performed safely and efficiently with minimal resource and storage requirements compared with venous blood (VB). Here, the use of selective whole genome amplification (sWGA) to sequence the P. falciparum genome from clinical DBS samples was evaluated, and the results compared with current methods that use leucodepleted VB. Parasite DNA with high (>95%) human DNA contamination was selectively amplified by Phi29 polymerase using short oligonucleotide probes of 8–12 mers as primers. These primers were selected on the basis of their differential frequency of binding the desired (P. falciparum DNA) and contaminating (human) genomes. Using sWGA method, clinical samples from 156 malaria patients, including 120 paired samples for head-to-head comparison of DBS and leucodepleted VB were sequenced. Greater than 18-fold enrichment of P. falciparum DNA was achieved from DBS extracts. The parasitaemia threshold to achieve >5× coverage for 50% of the genome was 0.03% (40 parasites per 200 white blood cells). Over 99% SNP concordance between VB and DBS samples was achieved after excluding missing calls. The sWGA methods described here provide a reliable and scalable way of generating P. falciparum genome sequence data from DBS samples. The current data indicate that it will be possible to get good quality sequence on most if not all drug resistance loci from the majority of symptomatic malaria patients. This technique overcomes a major limiting factor in P. falciparum genome sequencing from field samples, and paves the way for large-scale epidemiological applications.
- 20 December 2016
- Published by Springer Nature in Malaria Journal
- Vol. 15 (1) , 1-12
Top Cited PapersOpen AccessWhole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification
Translating genomic technologies into healthcare applications for the malaria parasite Plasmodium falciparum has been limited by the technical and logistical difficulties of obtaining high quality clinical samples from the field. Sampling by dried blood spot (DBS) finger-pricks can be performed safely and efficiently with minimal resource and storage requirements compared with venous blood (VB). Here, the use of selective whole genome amplification (sWGA) to sequence the P. falciparum genome from clinical DBS samples was evaluated, and the results compared with current methods that use leucodepleted VB. Parasite DNA with high (>95%) human DNA contamination was selectively amplified by Phi29 polymerase using short oligonucleotide probes of 8–12 mers as primers. These primers were selected on the basis of their differential frequency of binding the desired (P. falciparum DNA) and contaminating (human) genomes. Using sWGA method, clinical samples from 156 malaria patients, including 120 paired samples for head-to-head comparison of DBS and leucodepleted VB were sequenced. Greater than 18-fold enrichment of P. falciparum DNA was achieved from DBS extracts. The parasitaemia threshold to achieve >5× coverage for 50% of the genome was 0.03% (40 parasites per 200 white blood cells). Over 99% SNP concordance between VB and DBS samples was achieved after excluding missing calls. The sWGA methods described here provide a reliable and scalable way of generating P. falciparum genome sequence data from DBS samples. The current data indicate that it will be possible to get good quality sequence on most if not all drug resistance loci from the majority of symptomatic malaria patients. This technique overcomes a major limiting factor in P. falciparum genome sequencing from field samples, and paves the way for large-scale epidemiological applications.
- Open Access
- 1 September 2014
- Published by Elsevier in EuPA Open Proteomics
- Vol. 4, 184-194
Proteomic and genomic analysis reveals novel Campylobacter jejuni outer membrane proteins and potential heterogeneity
- 1 September 2014
- Published by Elsevier in EuPA Open Proteomics
- Vol. 4, 184-194
Open AccessProteomic and genomic analysis reveals novel Campylobacter jejuni outer membrane proteins and potential heterogeneity
- Open Access
- 8 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e96486
A Genome Wide Association Study of Plasmodium falciparum Susceptibility to 22 Antimalarial Drugs in Kenya
Drug resistance remains a chief concern for malaria control. In order to determine the genetic markers of drug resistant parasites, we tested the genome-wide associations (GWA) of sequence-based genotypes from 35 Kenyan P. falciparum parasites with the activities of 22 antimalarial drugs. Parasites isolated from children with acute febrile malaria were adapted to culture, and sensitivity was determined by in vitro growth in the presence of anti-malarial drugs. Parasites were genotyped using whole genome sequencing techniques. Associations between 6250 single nucleotide polymorphisms (SNPs) and resistance to individual anti-malarial agents were determined, with false discovery rate adjustment for multiple hypothesis testing. We identified expected associations in the pfcrt region with chloroquine (CQ) activity, and other novel loci associated with amodiaquine, quinazoline, and quinine activities. Signals for CQ and primaquine (PQ) overlap in and around pfcrt, and interestingly the phenotypes are inversely related for these two drugs. We catalog the variation in dhfr, dhps, mdr1, nhe, and crt, including novel SNPs, and confirm the presence of a dhfr-164L quadruple mutant in coastal Kenya. Mutations implicated in sulfadoxine-pyrimethamine resistance are at or near fixation in this sample set. Sequence-based GWA studies are powerful tools for phenotypic association tests. Using this approach on falciparum parasites from coastal Kenya we identified known and previously unreported genes associated with phenotypic resistance to anti-malarial drugs, and observe in high-resolution haplotype visualizations a possible signature of an inverse selective relationship between CQ and PQ.
- 8 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e96486
Open AccessA Genome Wide Association Study of Plasmodium falciparum Susceptibility to 22 Antimalarial Drugs in Kenya
Drug resistance remains a chief concern for malaria control. In order to determine the genetic markers of drug resistant parasites, we tested the genome-wide associations (GWA) of sequence-based genotypes from 35 Kenyan P. falciparum parasites with the activities of 22 antimalarial drugs. Parasites isolated from children with acute febrile malaria were adapted to culture, and sensitivity was determined by in vitro growth in the presence of anti-malarial drugs. Parasites were genotyped using whole genome sequencing techniques. Associations between 6250 single nucleotide polymorphisms (SNPs) and resistance to individual anti-malarial agents were determined, with false discovery rate adjustment for multiple hypothesis testing. We identified expected associations in the pfcrt region with chloroquine (CQ) activity, and other novel loci associated with amodiaquine, quinazoline, and quinine activities. Signals for CQ and primaquine (PQ) overlap in and around pfcrt, and interestingly the phenotypes are inversely related for these two drugs. We catalog the variation in dhfr, dhps, mdr1, nhe, and crt, including novel SNPs, and confirm the presence of a dhfr-164L quadruple mutant in coastal Kenya. Mutations implicated in sulfadoxine-pyrimethamine resistance are at or near fixation in this sample set. Sequence-based GWA studies are powerful tools for phenotypic association tests. Using this approach on falciparum parasites from coastal Kenya we identified known and previously unreported genes associated with phenotypic resistance to anti-malarial drugs, and observe in high-resolution haplotype visualizations a possible signature of an inverse selective relationship between CQ and PQ.
- Top Cited PapersOpen Access
- 28 April 2013
- Published by Springer Nature in Nature Genetics
- Vol. 45 (6) , 648-655
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Dominic Kwiatkowski and colleagues report analysis of genetic variation in 826 Plasmodium falciparum samples collected from 10 locations in West Africa and southeast Asia. They characterize the population structure of this parasite in Cambodia and find evidence for multiple distinct subpopulations showing high levels of genetic differentiation and artemisinin resistance. We describe an analysis of genome variation in 825 P. falciparum samples from Asia and Africa that identifies an unusual pattern of parasite population structure at the epicenter of artemisinin resistance in western Cambodia. Within this relatively small geographic area, we have discovered several distinct but apparently sympatric parasite subpopulations with extremely high levels of genetic differentiation. Of particular interest are three subpopulations, all associated with clinical resistance to artemisinin, which have skewed allele frequency spectra and high levels of haplotype homozygosity, indicative of founder effects and recent population expansion. We provide a catalog of SNPs that show high levels of differentiation in the artemisinin-resistant subpopulations, including codon variants in transporter proteins and DNA mismatch repair proteins. These data provide a population-level genetic framework for investigating the biological origins of artemisinin resistance and for defining molecular markers to assist in its elimination.
- 28 April 2013
- Published by Springer Nature in Nature Genetics
- Vol. 45 (6) , 648-655
Top Cited PapersOpen AccessMultiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Dominic Kwiatkowski and colleagues report analysis of genetic variation in 826 Plasmodium falciparum samples collected from 10 locations in West Africa and southeast Asia. They characterize the population structure of this parasite in Cambodia and find evidence for multiple distinct subpopulations showing high levels of genetic differentiation and artemisinin resistance. We describe an analysis of genome variation in 825 P. falciparum samples from Asia and Africa that identifies an unusual pattern of parasite population structure at the epicenter of artemisinin resistance in western Cambodia. Within this relatively small geographic area, we have discovered several distinct but apparently sympatric parasite subpopulations with extremely high levels of genetic differentiation. Of particular interest are three subpopulations, all associated with clinical resistance to artemisinin, which have skewed allele frequency spectra and high levels of haplotype homozygosity, indicative of founder effects and recent population expansion. We provide a catalog of SNPs that show high levels of differentiation in the artemisinin-resistant subpopulations, including codon variants in transporter proteins and DNA mismatch repair proteins. These data provide a population-level genetic framework for investigating the biological origins of artemisinin resistance and for defining molecular markers to assist in its elimination.
- Top Cited PapersOpen Access
- 13 June 2012
- Published by Springer Nature in Nature
- Vol. 487 (7407) , 375-379
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing
Next-generation sequencing is used here to analyse Plasmodium falciparum genome variation directly from clinical blood samples, as well as cultured isolates, from Africa, Asia and Oceania. Resistance to the major antimalarial drug artemisinin is emerging in the Plasmodium falciparum parasite across Southeast Asia, and there is concern that the increased deployment of antimalarials in pursuit of disease eradication might simply lead to increased drug resistance. To monitor these risks it is important to survey the parasite population for genetic changes. Next-generation sequencing is used here to analyse P. falciparum genome variation directly from nearly 300 clinical blood samples, and from cultured isolates from Africa, Asia and Oceania. The authors use these data to analyse the diversity of the parasite population across different geographical locations, as well as within-host diversity at the level of the whole genome, and they show how this may be used to estimate inbreeding rates, which are important for the evolution of drug resistance. Malaria elimination strategies require surveillance of the parasite population for genetic changes that demand a public health response, such as new forms of drug resistance1,2. Here we describe methods for the large-scale analysis of genetic variation in Plasmodium falciparum by deep sequencing of parasite DNA obtained from the blood of patients with malaria, either directly or after short-term culture. Analysis of 86,158 exonic single nucleotide polymorphisms that passed genotyping quality control in 227 samples from Africa, Asia and Oceania provides genome-wide estimates of allele frequency distribution, population structure and linkage disequilibrium. By comparing the genetic diversity of individual infections with that of the local parasite population, we derive a metric of within-host diversity that is related to the level of inbreeding in the population. An open-access web application has been established for the exploration of regional differences in allele frequency and of highly differentiated loci in the P. falciparum genome.
- 13 June 2012
- Published by Springer Nature in Nature
- Vol. 487 (7407) , 375-379
Top Cited PapersOpen AccessAnalysis of Plasmodium falciparum diversity in natural infections by deep sequencing
Next-generation sequencing is used here to analyse Plasmodium falciparum genome variation directly from clinical blood samples, as well as cultured isolates, from Africa, Asia and Oceania. Resistance to the major antimalarial drug artemisinin is emerging in the Plasmodium falciparum parasite across Southeast Asia, and there is concern that the increased deployment of antimalarials in pursuit of disease eradication might simply lead to increased drug resistance. To monitor these risks it is important to survey the parasite population for genetic changes. Next-generation sequencing is used here to analyse P. falciparum genome variation directly from nearly 300 clinical blood samples, and from cultured isolates from Africa, Asia and Oceania. The authors use these data to analyse the diversity of the parasite population across different geographical locations, as well as within-host diversity at the level of the whole genome, and they show how this may be used to estimate inbreeding rates, which are important for the evolution of drug resistance. Malaria elimination strategies require surveillance of the parasite population for genetic changes that demand a public health response, such as new forms of drug resistance1,2. Here we describe methods for the large-scale analysis of genetic variation in Plasmodium falciparum by deep sequencing of parasite DNA obtained from the blood of patients with malaria, either directly or after short-term culture. Analysis of 86,158 exonic single nucleotide polymorphisms that passed genotyping quality control in 227 samples from Africa, Asia and Oceania provides genome-wide estimates of allele frequency distribution, population structure and linkage disequilibrium. By comparing the genetic diversity of individual infections with that of the local parasite population, we derive a metric of within-host diversity that is related to the level of inbreeding in the population. An open-access web application has been established for the exploration of regional differences in allele frequency and of highly differentiated loci in the P. falciparum genome.